The aim of our study was to evaluate the diagnostic accuracy of serum AFP and PIVKA‐II or their combination in HCC diagnosis among Caucasian patients with compensated or decompensated liver cirrhosis of various etiologies. This evidence concerns the gene AFP and hepatocellular carcinoma.